Anaqua forms partnership to trial COVID-19 medicines

Anaqua’s ideaPoint has formed a strategic partnership with specialised clinical trials company WideTrial, in order to drive greater access to investigational medicines for physicians and patients dealing with COVID-19 worldwide.

View the original article here: Anaqua forms partnership to trial COVID-19 medicines

The article was originally posted on IPMagazine.
Each article is copyrighted to their original authors. We do not own any rights to the news or the images used. Whilst every care is taken to ensure that the news posts published are accurate, we cannot guarantee the authenticity of the news article on every occasion. There’s no copyright infringement intended. The news is for informational purposes only and does not provide legal advice.